Icon

PEMETREXED (nda208419)- (1GM/40ML (25MG/ML),100MG/4ML (25MG/ML),500MG/20ML (25MG/ML))

PEMETREXED ACTAVIS
1GM/40ML (25MG/ML),100MG/4ML (25MG/ML),500MG/20ML (25MG/ML)
No Yes
Expired Expired
None None
None No
Pemetrexed Injection is a folate analog metabolic inhibitor indicated:  as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.  as a single agent for the treatment of patients with recurrent, metastatic non-squamous, NSCLC after prior chemotherapy.
0 0 0
Total Other Developers 2
Drugs with Suitability No
1GM/40ML (25MG/ML) ** ** - - -
100MG/4ML (25MG/ML) ** ** - - -
500MG/20ML (25MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.